Table 2

Summary of procedure outcomes

CharacteristicOverall (n=112)30 day cohort (n=66)12 month cohort (n=46)
Treatment after embolization (n (%))
 None45 (40.2)24 (36.4)21 (45.7)
 Radiosurgery5 (4.5)1 (1.5)4 (8.7)
 Surgical resection62 (55.4)41 (62.1)21 (45.7)
Number of pedicles embolized (mean±SD)1.9±2.01.8±1.72.1±2.4
AVM obliteration percentage (n=111) (n (%))
 >80–100%13 (11.7)10 (15.4)3 (6.5)
 >60–80%8 (7.2)3 (4.6)5 (10.9)
 >40–60%9 (8.1)2 (3.1)7 (15.2)
 >20–40%13 (11.7)7 (10.8)6 (13.0)
 >0–20%68 (61.3)43 (66.2)25 (54.3)
AVM cured (n (%))64 (57.1)37 (56.1)27 (58.7)
Onyx deployed (n (%))101 (90.2)57 (86.4)44 (95.7)
 Tip detached67 (59.8)23 (34.8)44 (95.7)
 Unintentional1 (1.5)0 (0.0)1 (2.3)
No Onyx injected (n (%))11 (9.8)9 (13.6)2 (4.3)
 Tip detached2 (1.8)0 (0.0)2 (4.3)
 Unintentional1 (50.0)0 (0.0)1 (50.0)
Further treatment planned (n (%))
 None69 (61.6)37 (56.1)32 (69.6)
 Surgery21 (18.8)14 (21.2)7 (15.2)
 Radiosurgery9 (8.0)5 (7.6)4 (8.7)
 Radiosurgery and surgery1 (0.9)0 (0.0)1 (2.2)
 Further embolization8 (7.1)6 (9.1)2 (4.3)
 Unknown4 (3.6)4 (6.1)0 (0.0)
  • AVM, arteriovenous malformation.